优化恩福图马布维多丁加布罗利祖马布治疗的优化
Elias Antoine Karam1,2, Yaghi César Céline2, Gilles Prince2
1Departements de Médecine Oncologique, Gustave Roussy F-94805, Villejuif, France.
Oncotarget
|June 17, 2025
概括
晚期泌尿腺癌 (aUC) 治疗正在转向免疫疗法. 恩福图马布 (enfortumab) 与布罗利祖马布 ( pembrolizumab) 的组合显示,晚期泌尿器癌患者的生存率有所改善.
科学领域:
- 在瘤学瘤学.
- 尿癌研究 尿癌研究
- 癌症治疗方法 癌症治疗方法
背景情况:
- 晚期泌尿腺癌 (AUC) 的预后不好,通常涉及肌肉侵入性或转移性阶段.
- 化疗一直是aUC的传统治疗方法,但其在晚期的疗效是有限的.
研究的目的:
- 审查晚期泌尿腺癌治疗策略的演变.
- 突出免疫疗法和向治疗在aUC管理中的越来越重要的作用.
- 讨论优化治疗算法,以改善患者的治疗结果.
主要方法:
- 对晚期泌尿腺癌治疗策略的文献综述.
- 分析最近的临床试验数据,包括EV-302试验.
- 讨论新兴疗法及其对患者生存的影响.
主要成果:
- 恩福图马布维多丁与潘布罗利祖马布的组合现在是对aUC的推一线治疗.
- 这种新型组合疗法已经显示出生存率的显著改善.
- 在aUC治疗中显而易见的转向免疫疗法和向治疗的明显转变.
结论:
- 最近的治疗进展,特别是恩福图马布维多丁加上布罗利祖马布,为晚期泌尿腺癌提供了更好的治疗结果.
- 结合新药的优化治疗算法对于提高aUC的患者存活率至关重要.
- 治疗aUC的景观正在迅速发展,免疫疗法发挥着中心作用.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


